Metabolomic Studies of Oral Biofilm, Oral Cancer, and Beyond
AbstractOral diseases are known to be closely associated with oral biofilm metabolism, while cancer tissue is reported to possess specific metabolism such as the ‘Warburg effect’. Metabolomics might be a useful method for clarifying the whole metabolic systems that operate in oral biofilm and oral cancer, however, technical limitations have hampered such research. Fortunately, metabolomics techniques have developed rapidly in the past decade, which has helped to solve these difficulties. In vivo metabolomic analyses of the oral biofilm have produced various findings. Some of these findings agreed with the in vitro results obtained in conventional metabolic studies using representative oral bacteria, while others differed markedly from them. Metabolomic analyses of oral cancer tissue not only revealed differences between metabolomic profiles of cancer and normal tissue, but have also suggested a specific metabolic system operates in oral cancer tissue. Saliva contains a variety of metabolites, some of which might be associated with oral or systemic disease; therefore, metabolomics analysis of saliva could be useful for identifying disease-specific biomarkers. Metabolomic analyses of the oral biofilm, oral cancer, and saliva could contribute to the development of accurate diagnostic, techniques, safe and effective treatments, and preventive strategies for oral and systemic diseases. View Full-Text
Share & Cite This Article
Washio, J.; Takahashi, N. Metabolomic Studies of Oral Biofilm, Oral Cancer, and Beyond. Int. J. Mol. Sci. 2016, 17, 870.
Washio J, Takahashi N. Metabolomic Studies of Oral Biofilm, Oral Cancer, and Beyond. International Journal of Molecular Sciences. 2016; 17(6):870.Chicago/Turabian Style
Washio, Jumpei; Takahashi, Nobuhiro. 2016. "Metabolomic Studies of Oral Biofilm, Oral Cancer, and Beyond." Int. J. Mol. Sci. 17, no. 6: 870.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.